Proteasomal inhibition and apoptosis regulatory changes in human isolated lymphocytes: The synergistic role of dopamine

Eleonora Bazzini, Alberta Samuele, Marcella Granelli, Giovanna Levandis, Marie Therese Armentero, Giuseppe Nappi, Fabio Blandini

Research output: Contribution to journalArticle

Abstract

Abnormal deposition of protein aggregates and increased susceptibility to apoptotic cell death may result from defects in the activity of the ubiquitin-proteasome system (UPS); neurotoxicity related to UPS defects seems to require dopamine to be fully expressed. The aim of this study was to investigate the pro-apoptotic effects caused by proteasomal activity inhibition, as well as the synergistic effect of dopaminergic stimulation in human lymphocytes isolated from healthy volunteers. Cells were incubated 20 h at 37°C, with: (1) lactacystin, (2) increasing concentrations of dopamine or (3) mixture of dopamine and lactacystin. Activities of proteasome 20S and pro-apoptotic caspases-3 and -9 and levels of anti-apoptotic Bcl-2 were measured with fluorimetric or immunochemical assays, while a "DNA diffusion" assay was used to determine the apoptosis. Incubation of lymphocytes with lactacystin, which caused reduction of proteasomal activity, was associated with activation of caspases. A clear, dose-dependent reduction of proteasomal activity was also seen in the presence of increasing doses of dopamine, which was accompanied by a slight dose-dependent increase of caspases activities and Bcl-2 levels. Both effects on proteasome and caspase activities were enhanced when cells were simultaneously exposed to lactacystin and elevated concentrations of dopamine. Apoptosis was detected in all treated samples, but not in controls, without significant differences among the treatment groups; however, the association of dopamine and lactacystin induced a clear reduction in the number of cells being analyzed, pointing to marked cytotoxicity. Our data confirm the potentiation of cytotoxicity related to proteasome inhibition, in the presence of dopaminergic stimulation.

Original languageEnglish
Pages (from-to)877-885
Number of pages9
JournalJournal of Cellular Biochemistry
Volume103
Issue number3
DOIs
Publication statusPublished - Feb 15 2008

Fingerprint

Lymphocytes
Proteasome Endopeptidase Complex
Dopamine
Apoptosis
Caspases
Cytotoxicity
Ubiquitin
Assays
Defects
Caspase 9
Cell death
Caspase 3
Healthy Volunteers
Cell Death
Thermodynamic properties
Cell Count
Chemical activation
lactacystin
Association reactions
DNA

Keywords

  • Caspase activity
  • Dopamine
  • Impaired proteasome activity
  • Lactacystin
  • Neurodegeneration

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology

Cite this

Proteasomal inhibition and apoptosis regulatory changes in human isolated lymphocytes : The synergistic role of dopamine. / Bazzini, Eleonora; Samuele, Alberta; Granelli, Marcella; Levandis, Giovanna; Armentero, Marie Therese; Nappi, Giuseppe; Blandini, Fabio.

In: Journal of Cellular Biochemistry, Vol. 103, No. 3, 15.02.2008, p. 877-885.

Research output: Contribution to journalArticle

Bazzini, Eleonora ; Samuele, Alberta ; Granelli, Marcella ; Levandis, Giovanna ; Armentero, Marie Therese ; Nappi, Giuseppe ; Blandini, Fabio. / Proteasomal inhibition and apoptosis regulatory changes in human isolated lymphocytes : The synergistic role of dopamine. In: Journal of Cellular Biochemistry. 2008 ; Vol. 103, No. 3. pp. 877-885.
@article{9a3da77c66a44814b422c1cb13400e7b,
title = "Proteasomal inhibition and apoptosis regulatory changes in human isolated lymphocytes: The synergistic role of dopamine",
abstract = "Abnormal deposition of protein aggregates and increased susceptibility to apoptotic cell death may result from defects in the activity of the ubiquitin-proteasome system (UPS); neurotoxicity related to UPS defects seems to require dopamine to be fully expressed. The aim of this study was to investigate the pro-apoptotic effects caused by proteasomal activity inhibition, as well as the synergistic effect of dopaminergic stimulation in human lymphocytes isolated from healthy volunteers. Cells were incubated 20 h at 37°C, with: (1) lactacystin, (2) increasing concentrations of dopamine or (3) mixture of dopamine and lactacystin. Activities of proteasome 20S and pro-apoptotic caspases-3 and -9 and levels of anti-apoptotic Bcl-2 were measured with fluorimetric or immunochemical assays, while a {"}DNA diffusion{"} assay was used to determine the apoptosis. Incubation of lymphocytes with lactacystin, which caused reduction of proteasomal activity, was associated with activation of caspases. A clear, dose-dependent reduction of proteasomal activity was also seen in the presence of increasing doses of dopamine, which was accompanied by a slight dose-dependent increase of caspases activities and Bcl-2 levels. Both effects on proteasome and caspase activities were enhanced when cells were simultaneously exposed to lactacystin and elevated concentrations of dopamine. Apoptosis was detected in all treated samples, but not in controls, without significant differences among the treatment groups; however, the association of dopamine and lactacystin induced a clear reduction in the number of cells being analyzed, pointing to marked cytotoxicity. Our data confirm the potentiation of cytotoxicity related to proteasome inhibition, in the presence of dopaminergic stimulation.",
keywords = "Caspase activity, Dopamine, Impaired proteasome activity, Lactacystin, Neurodegeneration",
author = "Eleonora Bazzini and Alberta Samuele and Marcella Granelli and Giovanna Levandis and Armentero, {Marie Therese} and Giuseppe Nappi and Fabio Blandini",
year = "2008",
month = "2",
day = "15",
doi = "10.1002/jcb.21457",
language = "English",
volume = "103",
pages = "877--885",
journal = "Journal of Cellular Biochemistry",
issn = "0730-2312",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Proteasomal inhibition and apoptosis regulatory changes in human isolated lymphocytes

T2 - The synergistic role of dopamine

AU - Bazzini, Eleonora

AU - Samuele, Alberta

AU - Granelli, Marcella

AU - Levandis, Giovanna

AU - Armentero, Marie Therese

AU - Nappi, Giuseppe

AU - Blandini, Fabio

PY - 2008/2/15

Y1 - 2008/2/15

N2 - Abnormal deposition of protein aggregates and increased susceptibility to apoptotic cell death may result from defects in the activity of the ubiquitin-proteasome system (UPS); neurotoxicity related to UPS defects seems to require dopamine to be fully expressed. The aim of this study was to investigate the pro-apoptotic effects caused by proteasomal activity inhibition, as well as the synergistic effect of dopaminergic stimulation in human lymphocytes isolated from healthy volunteers. Cells were incubated 20 h at 37°C, with: (1) lactacystin, (2) increasing concentrations of dopamine or (3) mixture of dopamine and lactacystin. Activities of proteasome 20S and pro-apoptotic caspases-3 and -9 and levels of anti-apoptotic Bcl-2 were measured with fluorimetric or immunochemical assays, while a "DNA diffusion" assay was used to determine the apoptosis. Incubation of lymphocytes with lactacystin, which caused reduction of proteasomal activity, was associated with activation of caspases. A clear, dose-dependent reduction of proteasomal activity was also seen in the presence of increasing doses of dopamine, which was accompanied by a slight dose-dependent increase of caspases activities and Bcl-2 levels. Both effects on proteasome and caspase activities were enhanced when cells were simultaneously exposed to lactacystin and elevated concentrations of dopamine. Apoptosis was detected in all treated samples, but not in controls, without significant differences among the treatment groups; however, the association of dopamine and lactacystin induced a clear reduction in the number of cells being analyzed, pointing to marked cytotoxicity. Our data confirm the potentiation of cytotoxicity related to proteasome inhibition, in the presence of dopaminergic stimulation.

AB - Abnormal deposition of protein aggregates and increased susceptibility to apoptotic cell death may result from defects in the activity of the ubiquitin-proteasome system (UPS); neurotoxicity related to UPS defects seems to require dopamine to be fully expressed. The aim of this study was to investigate the pro-apoptotic effects caused by proteasomal activity inhibition, as well as the synergistic effect of dopaminergic stimulation in human lymphocytes isolated from healthy volunteers. Cells were incubated 20 h at 37°C, with: (1) lactacystin, (2) increasing concentrations of dopamine or (3) mixture of dopamine and lactacystin. Activities of proteasome 20S and pro-apoptotic caspases-3 and -9 and levels of anti-apoptotic Bcl-2 were measured with fluorimetric or immunochemical assays, while a "DNA diffusion" assay was used to determine the apoptosis. Incubation of lymphocytes with lactacystin, which caused reduction of proteasomal activity, was associated with activation of caspases. A clear, dose-dependent reduction of proteasomal activity was also seen in the presence of increasing doses of dopamine, which was accompanied by a slight dose-dependent increase of caspases activities and Bcl-2 levels. Both effects on proteasome and caspase activities were enhanced when cells were simultaneously exposed to lactacystin and elevated concentrations of dopamine. Apoptosis was detected in all treated samples, but not in controls, without significant differences among the treatment groups; however, the association of dopamine and lactacystin induced a clear reduction in the number of cells being analyzed, pointing to marked cytotoxicity. Our data confirm the potentiation of cytotoxicity related to proteasome inhibition, in the presence of dopaminergic stimulation.

KW - Caspase activity

KW - Dopamine

KW - Impaired proteasome activity

KW - Lactacystin

KW - Neurodegeneration

UR - http://www.scopus.com/inward/record.url?scp=39049150055&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39049150055&partnerID=8YFLogxK

U2 - 10.1002/jcb.21457

DO - 10.1002/jcb.21457

M3 - Article

C2 - 17647258

AN - SCOPUS:39049150055

VL - 103

SP - 877

EP - 885

JO - Journal of Cellular Biochemistry

JF - Journal of Cellular Biochemistry

SN - 0730-2312

IS - 3

ER -